Modulating apoptosis as a novel therapeutic strategy against Respiratory Syncytial Virus infection: insights from...

Area of Science:

• Virology
• Immunology
• Cell Biology

Background:

• Respiratory syncytial virus (RSV) causes severe respiratory infections, particularly in infants, leading to bronchiolitis and pneumonia.
• RSV is a major contributor to mortality in children under five globally.
• Understanding hypervirulent RSV strains is crucial for developing effective treatments.

Purpose of the Study:

• Investigate the pathogenicity of a lethal RSV strain (GZ08-18) as a model for hypervirulent RSV.
• Determine if enhancing intrinsic apoptosis can reduce RSV virulence.
• Evaluate the therapeutic potential of Rotenone, an intrinsic apoptosis inducer, against RSV infection.

Main Methods:

• Utilized a lethal RSV strain (GZ08-18) to study hypervirulence mechanisms.
• Assessed host cell intrinsic apoptosis and mitochondrial membrane potential.
• Administered Rotenone to RSV-infected mice to evaluate its therapeutic effects on survival and lung pathology.

Main Results:

• The hypervirulent RSV strain GZ08-18 exhibited compromised intrinsic apoptosis activation and mitochondrial membrane depolarization.
• Rotenone treatment significantly increased survival rates in mice infected with GZ08-18.
• Rotenone administration mitigated lung pathology associated with GZ08-18 infection.

Conclusions:

• Suppressed intrinsic apoptosis is a key mechanism contributing to the hypervirulence of certain RSV strains.
• Modulating the intrinsic apoptosis pathway offers a promising strategy for developing novel antiviral interventions against RSV.
• Rotenone demonstrates therapeutic potential in reducing RSV-induced mortality and lung damage.